Straumann Holding AG Shares Outstanding 2012-2021 | SAUHY

Straumann Holding AG shares outstanding history from 2012 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Straumann Holding AG shares outstanding for the quarter ending December 31, 2021 were M, a NAN% increase year-over-year.
  • Straumann Holding AG 2021 shares outstanding were 1.596B, a 0.21% increase from 2020.
  • Straumann Holding AG 2020 shares outstanding were 1.593B, a 0.07% increase from 2019.
  • Straumann Holding AG 2019 shares outstanding were 1.591B, a 0.21% increase from 2018.
Straumann Holding AG Annual Shares Outstanding
(Millions of Shares)
2021 1,596
2020 1,593
2019 1,591
2018 1,588
2017 1,557
2016 1,573
2015 1,583
2014 1,574
2013 1,545
2012 1,544
2011
Straumann Holding AG Quarterly Shares Outstanding
(Millions of Shares)
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09